C-CG0ZAspen Neuroscience
autologous iPSC, neuron replacement, advanced genomics
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-CG0Z
C-CG0ZC-CG0Zautologous iPSC, neuron replacement, advanced genomics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Aspen Neuroscience’s stated belief is that Parkinson’s disease can be addressed with personalized regenerative medicine that begins with the patient’s own cells. The company presents its approach as using a patient’s skin cells to create induced pluripotent stem cells and then dopamine-producing neurons for transplantation, based on the view that replacing lost dopamine neurons can restore function while an autologous approach may reduce immune rejection and the need for immunosuppression.
SourceAspen Neuroscience states that Parkinson disease can be treated with a personalized cell therapy built from a patient’s own cells, and presents itself as the only company offering a personalized approach intended to safely “turn the clock back” on Parkinson disease. It says this approach uses stem cell biology and genomics to create autologous induced pluripotent stem cell-derived neuron replacement therapy for both idiopathic and familial Parkinson disease.
SourceAspen Neuroscience presents the view that personalized cell therapy should begin with the patient, using a patient’s own cells to create autologous neuron replacement therapies for Parkinson’s disease. The company frames its approach as combining stem cell biology and genomics to replace lost dopamine neurons and potentially restore lost function, with patients placed at the center of the company’s decisions.
SourceAspen Neuroscience presents a belief that personalized regenerative medicine can treat Parkinson's disease by using a patient's own skin cells, reprogramming them into induced pluripotent stem cells, and turning those cells into dopaminergic neurons, while applying genomic quality control to ensure the resulting cells are high quality and free of harmful mutations.
Source